Matches in Nanopublications for { ?s ?p "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 22 of
22
with 100 items per page.
- NP677920.RACCn3F-ycTDsPTs8su_ep-U98v1cQhGIdBkxg8_JCLQ4130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677920.RACCn3F-ycTDsPTs8su_ep-U98v1cQhGIdBkxg8_JCLQ4130_provenance.
- NP817159.RAWNFebik5HBhQhOyDV4LFRBFuV3TFn2pwR75IIgreyq8130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817159.RAWNFebik5HBhQhOyDV4LFRBFuV3TFn2pwR75IIgreyq8130_provenance.
- NP510128.RAs23y3Q-WB3XqHIE1-eIEuY0PoT7hfTYF2FqFuuuhBoc130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510128.RAs23y3Q-WB3XqHIE1-eIEuY0PoT7hfTYF2FqFuuuhBoc130_provenance.
- NP679099.RA5Z05zlKJXcSUEEkSxtwqn5t0iE9PP69tzFueJzbfb9U130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679099.RA5Z05zlKJXcSUEEkSxtwqn5t0iE9PP69tzFueJzbfb9U130_provenance.
- NP782474.RAyJXDQDlI1BPdAucYxWsxHgZR1BqEXGGBQfJYaF0DBak130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782474.RAyJXDQDlI1BPdAucYxWsxHgZR1BqEXGGBQfJYaF0DBak130_provenance.
- NP761572.RAYQLNcCWpAsV6cg0Zp4E2Y6DljFw10ITk_-jksuhz1XY130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761572.RAYQLNcCWpAsV6cg0Zp4E2Y6DljFw10ITk_-jksuhz1XY130_provenance.
- NP761912.RAZNkGeJkPAFrFTZ2fQOVqm5VrhJOJw4DSsioEyJv2vcw130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761912.RAZNkGeJkPAFrFTZ2fQOVqm5VrhJOJw4DSsioEyJv2vcw130_provenance.
- NP828161.RAxIFT_3DoGJ9TNGdefh818HdqFBbhFmTBpb-z1ReWiEY130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828161.RAxIFT_3DoGJ9TNGdefh818HdqFBbhFmTBpb-z1ReWiEY130_provenance.
- assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP761540.RAhLijTpwBH276J4FRHHPqZ6-e6nucqhspEeaoODxePS8130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761540.RAhLijTpwBH276J4FRHHPqZ6-e6nucqhspEeaoODxePS8130_provenance.
- NP761883.RABYNJdjDh-PvadWSGkIesdtMGX0AGYNtz4TTUsyVOsrQ130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761883.RABYNJdjDh-PvadWSGkIesdtMGX0AGYNtz4TTUsyVOsrQ130_provenance.
- NP323386.RAA8mfGTYDUol8MeR4sLLxJF5KpAfZ_9j8kguVHAexUR8130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323386.RAA8mfGTYDUol8MeR4sLLxJF5KpAfZ_9j8kguVHAexUR8130_provenance.
- NP323385.RAYXJZ6lU65lUcR8GWWDLPX2n9h1bnjU0i0f4tAD4pm_A130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323385.RAYXJZ6lU65lUcR8GWWDLPX2n9h1bnjU0i0f4tAD4pm_A130_provenance.
- NP323384.RAlz4eNiaCRnxZU3nnfsJyCkK4UIP4MfrCFPsvEwGqpug130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323384.RAlz4eNiaCRnxZU3nnfsJyCkK4UIP4MfrCFPsvEwGqpug130_provenance.
- NP323388.RApAmHvT3Ea6_ZbPLBVMHTkQxO06u5KTUKoPoNEQ-K4kE130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323388.RApAmHvT3Ea6_ZbPLBVMHTkQxO06u5KTUKoPoNEQ-K4kE130_provenance.
- NP761689.RALVO26ogti4_kGAfGXJNiAFt7hl3wGbvPdwK2-lE8PTw130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761689.RALVO26ogti4_kGAfGXJNiAFt7hl3wGbvPdwK2-lE8PTw130_provenance.
- NP323383.RANyqu-kF40uzQ4ALXzLE8PkvS-tFLTyWSLGgPzLPvWac130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323383.RANyqu-kF40uzQ4ALXzLE8PkvS-tFLTyWSLGgPzLPvWac130_provenance.
- NP323387.RALyZrL-8RJjtSPkRwoOS_88BNOH5gMFoc18cni9q_IfE130_assertion description "[CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323387.RALyZrL-8RJjtSPkRwoOS_88BNOH5gMFoc18cni9q_IfE130_provenance.